Nina D. Russell - Concepedia

Author

Nina D. Russell

Fred Hutch Cancer Center ORCID

Also Known As

N. Russell, N.D. Russell, Nina D Russell, Nina D. Russell, Nina Russell, Nina D. Russell

Publications

869

Citations

H-Index

Concepts

All Affiliations

Fred Hutch Cancer Center University of Washington National Institutes of Health Duke University National Institute of Allergy and Infectious Diseases

About

Nina D. Russell is an author at Fred Hutch Cancer Center specializing in medicine, hiv, and vaccination.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	214
2	Public Health	2	2	52
3	Allergy	2	2	53
4	Nursing	1	1	11
5	Social Sciences	1	1	11

Nina D. Russell

Publications

672

Citations

H-Index

Page 1

	Year	Citations
Moving to Human Immunodeficiency Virus Type 1 Vaccine Efficacy Trials: Defining T Cell Responses As Potential Correlates of Immunity Nina D. Russell, Michael G. Hudgens, Richard Ha, The Journal of Infectious Diseases	2003	117
Phase 2 Study of an HIV-1 Canarypox Vaccine (vCP1452) Alone and in Combination With rgp120 Nina D. Russell, Barney S. Graham, Michael C. Keefer, JAIDS Journal of Acquired Immune Deficiency Syndromes	2006	104
Phase I Safety and Immunogenicity Evaluations of an Alphavirus Replicon HIV-1 Subtype C<i>gag</i>Vaccine in Healthy HIV-1-Uninfected Adults Margaret Wecker, Peter B. Gilbert, Nina D. Russell, Clinical and Vaccine Immunology	2012	67
Safety and immunogenicity of cytotoxic T-lymphocyte poly-epitope, DNA plasmid (EP HIV-1090) vaccine in healthy, human immunodeficiency virus type 1 (HIV-1)-uninfected adults Geoffrey J. Gorse, Lindsey R. Baden, Margaret Wecker, Vaccine VaccinationEp Hiv-1090Vaccine TargetHuman RetrovirusImmunology	2007	58
Safety and Immunogenicity of a Replication-Defective Adenovirus Type 5 HIV Vaccine in Ad5-Seronegative Persons: A Randomized Clinical Trial (HVTN 054) Cecilia Morgan, Zoe Moodie, Hongli Li, PLoS ONE	2010	51
Excellent Safety and Tolerability of the Human Immunodeficiency Virus Type 1 pGA2/JS2 Plasmid DNA Priming Vector Vaccine in HIV Type 1 Uninfected Adults Mark J. Mulligan, Nina D. Russell, Connie Celum, AIDS Research and Human Retroviruses	2006	44
Statistical considerations for the design and analysis of the ELISpot assay in HIV-1 vaccine trials Michael G. Hudgens, Steven G. Self, Ya-Lin Chiu, Journal of Immunological Methods VaccinationHiv-1 Vaccine TrialsTreatment And PreventionStatistical ConsiderationsVaccine Testing	2004	41
Correlation between Interferon‐γ Secretion and Cytotoxicity, in Virus‐Specific Memory T Cells Helen Horton, Nina D. Russell, Erin Moore, The Journal of Infectious Diseases Adaptive Immune SystemViral PathogenesisImmunologyT CellsImmune System	2004	41
Production of Protective Human Antipneumococcal Antibodies by Transgenic Mice with Human Immunoglobulin Loci Nina D. Russell, José R. F. Corvalán, Michael Gallo, Infection and Immunity	2000	40
Immune defence against HIV-1 infection in HIV-1-exposed seronegative persons Stephen C. Schmechel, Nina D. Russell, Florian Hladik, Immunology Letters Sexual HealthHuman RetrovirusImmunologyAntiviral ResponseChronic Viral Infection	2001	37

Page 1